VOCO IONOFIL MOLAR AC QUICK

K102612 · Voco GmbH · EMA · Nov 19, 2010 · Dental

Device Facts

Record IDK102612
Device NameVOCO IONOFIL MOLAR AC QUICK
ApplicantVoco GmbH
Product CodeEMA · Dental
Decision DateNov 19, 2010
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 872.3275
Device ClassClass 2
AttributesTherapeutic

Intended Use

VOCO lonofil Molar AC Quick is intended for the following applications: - restoration of V-shaped defects and cervical enamel or root erosions including class V cavities - restoration of deciduous teeth (especially class I) - fillings of class II cavities (non-occlusion-bearing) by means of tunnel preparations - build-up fillings and linings, core build-up - temporary long-term treatment of class I and II cavities

Device Story

VOCO Ionofil Molar AC Quick is a dental cement used by dentists in clinical settings for restorative procedures. It functions as a restorative material for various cavity classes and core build-ups. The device is applied directly to the prepared tooth structure to fill defects or build up tooth substance. It provides a restorative solution for patients requiring treatment of erosions, deciduous teeth, or temporary long-term cavity management. The clinician uses the material to restore tooth form and function, potentially benefiting the patient by preserving tooth structure and providing durable, long-term restorations.

Clinical Evidence

Bench testing only.

Technological Characteristics

Dental cement; glass ionomer restorative material. Formulated for chemical adhesion to tooth structure. Supplied as a capsule or powder/liquid system for mixing. Physical properties consistent with ISO standards for dental glass ionomer cements.

Indications for Use

Indicated for restoration of V-shaped defects, cervical enamel/root erosions, class V cavities, deciduous teeth (class I), non-occlusion-bearing class II cavities via tunnel preparations, core build-ups, and temporary long-term treatment of class I and II cavities.

Regulatory Classification

Identification

Zinc oxide-eugenol is a device composed of zinc oxide-eugenol intended to serve as a temporary tooth filling or as a base cement to affix a temporary tooth filling, to affix dental devices such as crowns or bridges, or to be applied to a tooth to protect the tooth pulp. Dental cement other than zinc oxide-eugenol is a device composed of various materials other than zinc oxide-eugenol intended to serve as a temporary tooth filling or as a base cement to affix a temporary tooth filling, to affix dental devices such as crowns or bridges, or to be applied to a tooth to protect the tooth pulp.

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized design featuring three abstract shapes resembling birds in flight, arranged in a descending order. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 Mr. Thorsten Gerkensmeier Regulatory Affairs VOCO GMBH Anton-Flettner-Strasse 1-3 Cuxhaven Germany D-27472 NOV 1 9 2010 Re: K102612 Trade/Device Name: VOCO lonofil Molar AC Quick Regulation Number: 21CFR 872.3275 Regulation Name: Dental Cement Regulatory Class: II Product Code: EMA Dated: September 8, 2010 Received: September 10, 2010 Dear Mr. Gerkensmeier: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Page 2- Mr. Gerkensmeier Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely vours. Th for Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology. General Hospital. Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## Indications for Use Statement 510(k) Number: K102612 Device Name: VOCO lonofil Molar AC Quick Indications for Use: VOCO lonofil Molar AC Quick is intended for the following applications: - restoration of V-shaped defects and cervical enamel or root erosions including class V cavities - restoration of deciduous teeth (especially class I) । - fillings of class II cavities (non-occlusion-bearing) by means of tunnel preparations - - build-up fillings and linings, core build-up - temporary long-term treatment of class I and II cavities Prescription Use X OR Over-The-Counter Use (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Susan Pearson (Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices 510(k) Number:
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%